Overview
A physician and clinic owner describes his experience during the COVID-19 pandemic, focusing on the shift in understanding COVID as a vascular rather than a respiratory disease, observations about vaccines (particularly mRNA types), and systemic issues in medical response and reporting.
Professional Background & Early Pandemic Response
- Physician with a background in internal medicine and clinic ownership, managing large patient and staff volumes.
- COVID-19 forced a rapid and deep dive into new medical knowledge, especially for patient and employee safety.
- Noted that expertise in COVID developed quickly among those who focused on learning due to the novelty of the situation.
Key Clinical Observations on COVID-19
- Early signs indicated COVID-19 acted as a vascular disease affecting blood vessels, not just a respiratory infection.
- Ventilation sometimes worsened outcomes due to increased pressure harming already compromised lung vessels.
- Focusing on vascular complications, especially coagulation and clotting, improved patient survival and recovery.
COVID-19 Vaccine Insights and Concerns
- Identified the spike protein as the main cause of vascular injury, targeting ACE2 receptors in blood vessels.
- Criticized mRNA vaccine approach for instructing the body to make the spike protein for uncertain durations and quantities.
- Highlighted differences between mRNA and adenovector vaccines in terms of technology and safety data history.
- Recent studies revealed spike protein distribution to organs beyond the injection site, challenging earlier safety claims.
- Questioned real-world vaccine impact on limiting COVID-19 deaths and raised concerns about mutation-driven vaccine inefficacy.
- Meta-analysis reported a 2% increase in autoimmune diseases among vaccinated children, which raises pediatric safety concerns.
Long COVID & Data Collection Issues
- Observed data confusion since the timing of symptoms is not linked to either infection or vaccination in studies.
- Lack of precise symptom chronology in research hampers understanding of long-term complications.
Critique of Medical Establishment & Reporting
- Describes medicine as hierarchical, discouraging questioning of mainstream narratives.
- Discussed failures of agencies (CDC, FDA, NIH) to transparently communicate emerging risks, notably myocarditis in young men.
- Decision to update CDC website instead of issuing active physician alerts limited effective response.
- Expressed that funding structures stifle independent thought and dissent in academic medicine.
Myocarditis & Other Adverse Effects
- Explained myocarditis as heart muscle inflammation with lifelong consequences, particularly in youth.
- mRNA vaccines linked to higher myocarditis cases in young men, potentially due to testosterone and catecholamine effects.
- Noted inadequate symptom tracking in official safety monitoring systems (e.g., VSafe).
- Cited increased rates of clotting dysfunction and abnormal fibrin formation, especially in small blood vessels, after COVID or vaccination.
Lessons Learned & System Reforms
- Advocated for open-minded, patient-centered medicine not constrained by bureaucratic or funding pressures.
- Supported recent policy changes requiring more rigorous trials and targeted vaccine use for high-risk groups.
- Highlighted leadership accountability, referencing regulatory officials promoting vaccines beyond their proper roles.
Recommendations / Advice
- Improve specificity and scope of adverse event monitoring in vaccine safety systems.
- Restore independent scientific inquiry and transparent reporting in healthcare leadership.
- Restrict new or high-risk interventions to those with clear need and supporting evidence.
- Maintain critical scrutiny of medical consensus and empower physicians to question and investigate new phenomena.